Dementia, Alzheimer Type Clinical Trial
Official title:
An Exploratory Placebo-Controlled, Dose-Ranging Study of the Effects of TRx0014 30 MG TID, 60 MG TID AND 100 MG TID in Patients With Mild or Moderate Dementia of the Alzheimer Type
The primary objective of the study is to investigate the effects of oral TRx0014 at three doses (30, 60 and 100 mg tid) compared with placebo on cognitive ability in patients with mild or moderate dementia of the Alzheimer type. Cognitive ability will be measured by the Alzheimer's Disease Assessment Scale - cognitive subscale (ADAS-cog). The primary evaluation will be made at 24 weeks.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT00154635 -
Efficacy and Safety Study of DCB-AD1 in Patients With Mild to Moderate Alzheimer’s Disease
|
Phase 2 | |
| Completed |
NCT00208819 -
A Comparison of Two Standard Therapies in the Management of Dementia With Agitation
|
Phase 4 | |
| Completed |
NCT00997425 -
Home Evaluation of Exit Barriers in Wandering
|
N/A | |
| Terminated |
NCT02322021 -
Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease
|
Phase 2 | |
| Completed |
NCT03119259 -
Technology Intervention to Support Caregiving for Alzheimer's Disease (I-CARE)
|
N/A | |
| Completed |
NCT00099242 -
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
|
Phase 3 | |
| Completed |
NCT03721705 -
Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type
|
Phase 3 | |
| Not yet recruiting |
NCT05113732 -
Association of Cognition With Functional Mobility in People With Alzheimer's Disease
|
||
| Active, not recruiting |
NCT03661034 -
Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)
|
N/A | |
| Completed |
NCT03160027 -
Photobiomodulation for Improving Brain Function in Dementia (PBM Dementia)
|
N/A | |
| Completed |
NCT03475316 -
Movement Intervention for Memory Enhancement
|
N/A | |
| Completed |
NCT02727699 -
A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu)
|
Phase 2 | |
| Completed |
NCT00259454 -
Project COPE:Managing Dementia at Home
|
Phase 3 | |
| Completed |
NCT00505167 -
Memantine Versus Donepezil in Early Stages of Alzheimer's Disease
|
Phase 4 | |
| Completed |
NCT03246269 -
Normative Values for the German Version of the Montreal Cognitive Assessment (MoCA)
|
||
| Recruiting |
NCT03890861 -
Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)"
|
N/A | |
| Completed |
NCT03991195 -
Intervention of Intestinal Microorganism in Mild Cognitive Impairment
|
N/A | |
| Completed |
NCT01438060 -
Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type
|
Phase 3 | |
| Completed |
NCT03622814 -
Partners at Meals - Respite Care and Home (PAM)
|
N/A | |
| Recruiting |
NCT03672266 -
Studies of Brain and Body Interaction
|